RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191 | -16.2% | 177,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $228 | -64.7% | 177,000 | -63.8% | 0.00% | 0.0% |
| Q1 2023 | $645 | +164.3% | 489,600 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $244 | -99.9% | 163,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $192,000 | +4.3% | 163,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $184,000 | -60.0% | 163,200 | +6.0% | 0.00% | -50.0% |
| Q1 2022 | $460,000 | +12.7% | 154,000 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $408,000 | -27.0% | 154,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $559,000 | -13.2% | 154,000 | -12.4% | 0.00% | -33.3% |
| Q3 2016 | $644,000 | +36.7% | 175,700 | -16.8% | 0.00% | +50.0% |
| Q2 2016 | $471,000 | +16.3% | 211,300 | +8.4% | 0.00% | 0.0% |
| Q1 2016 | $405,000 | -31.4% | 195,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $590,000 | +74.0% | 195,000 | +42.0% | 0.00% | +50.0% |
| Q3 2015 | $339,000 | -23.0% | 137,300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $440,000 | – | 137,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
| Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
| Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
| Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
| ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
| SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
| Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
| NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
| Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |